Enterocolitis, Pseudomembranous

• 

  Subject Areas on Research

  • A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile-associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation. 
  • A comparison between National Healthcare Safety Network laboratory-identified event reporting versus traditional surveillance for Clostridium difficile infection. 
  • A mathematical model to evaluate the routine use of fecal microbiota transplantation to prevent incident and recurrent Clostridium difficile infection. 
  • Acquisition of Clostridium difficile from the hospital environment. 
  • Analysis of enteric coagulase-negative staphylococci from neonates with necrotizing enterocolitis. 
  • Appendectomy and Clostridium difficile colitis: relationships revealed by clinical observations and immunology. 
  • Assessing the relative burden of hospital-acquired infections in a network of community hospitals. 
  • Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. 
  • Asymptomatic cecal stenosis after necrotizing enterocolitis. 
  • Blurred Lines: Dysbiosis and Probiotics in the ICU. 
  • Clostridium Difficile Infection from a Surgical Perspective. 
  • Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. 
  • Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report. 
  • Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population. 
  • Clostridium difficile infection in obstetric and gynecologic patients. 
  • Clostridium difficile: a new look at an old but increasingly deadly infection. 
  • Colonic uptake of Tc-99m MDP in pseudomembranous colitis. 
  • Combined medical and surgical management of severe pseudomembranous colitis. 
  • Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA. 
  • Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. 
  • Diarrhea, demography and cell signaling: lessons from microbial toxins. 
  • Distal ventriculoperitoneal shunt failure secondary to Clostridium difficile colitis. 
  • Enteral glutamine supplementation for very low birth weight infants decreases morbidity. 
  • Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis. 
  • Evaluation of eight cephalosporins in hamster colitis model. 
  • Evaluation of repeat Clostridium difficile enzyme immunoassay testing. 
  • Expert Consensus on Metrics to Assess the Impact of Patient-Level Antimicrobial Stewardship Interventions in Acute-Care Settings. 
  • Extrinsic surgical denervation inhibits Clostridium difficile toxin A-induced enteritis in rats. 
  • Getting to a Man's Heart through His Colon. 
  • Hospital-acquired Clostridium difficile infections: estimating all-cause mortality and length of stay. 
  • Impact of change to molecular testing for Clostridium difficile infection on healthcare facility-associated incidence rates. 
  • Inappropriate Clostridium difficile Testing and Consequent Overtreatment and Inaccurate Publicly Reported Metrics. 
  • Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. 
  • Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis. 
  • Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy. 
  • Necrotizing enterocolitis in the asphyxiated full-term infant. 
  • Neonatal complications after the administration of indomethacin for preterm labor. 
  • Nosocomial infections within the first month of solid organ transplantation. 
  • Proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. 
  • Pseudomembranous colitis presenting as mild, chronic diarrhea in childhood. 
  • Pseudomembranous colitis. 
  • Recommendations for surveillance of Clostridium difficile-associated disease. 
  • Severity of Clostridium difficile-associated diarrhea in solid organ transplant patients. 
  • Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis. 
  • Superior mesenteric artery flow velocity waveforms in small for gestational age fetuses. 
  • Tolevamer, an orally administered, toxin-binding polymer for Clostridium difficile-associated diarrhea. 
  • Vital signs: improving antibiotic use among hospitalized patients.